Two Versions: May 21 & May 24 [BE/BA News]

posted by Obinoscopy  – USA, 2018-07-30 20:41 (1271 d 01:25 ago) – Posting: # 19117
Views: 7,088

» But IS variations could be considered an assignable cause for analytical repeats.

Yes it is, but I think there is need to determine assignable cause for IS variations.

» I noticed there are two versions of the guidance on the internet. One is dated May 21, 2018 while the other is May 24, 2018.

» Could it be that the May 24 version is the updated and thus the recommended version to use? Was also wondering what was the modification done :ponder:

I have skimmed through both documents. I did not notice any difference except for a very negligible formatting difference: the May 24 document seemed a bit narrower.

If they are same, I wonder what the FDA did on the document for it to change from a size of 373KB to 386KB. I also wonder why the update if there were no changes made. My pondering continues :confused: :ponder:


Complete thread:

 Admin contact
21,834 posts in 4,569 threads, 1,554 registered users;
online 20 (1 registered, 19 guests [including 7 identified bots]).
Forum time: Friday 21:06 CET (Europe/Vienna)

No problem can stand the assault of sustained thinking.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz